Predicting effectiveness of flu vaccination campaigns

ScienceDaily (Feb. 22, 2010) ? A new study published in Vaccine describes a new method that assesses the impact and cost-effectiveness of a range of vaccination options. The model was applied to the 2009 influenza H1N1 outbreak and predicted accurately in real-time when the epidemic would peak and who should be prioritized for vaccination.

Last year, an outbreak of a novel strain of influenza linked to swine influenza was detected in Mexico. The infection has shown sustained human-to-human transmission across the world, leading the World Health Organization to declare an influenza pandemic. Vaccines specific for pandemic influenza have been successfully developed and the UK Joint Committee on Vaccination and Immunization recommended that high-risk individuals be prioritized for vaccination.

Decisions about extending vaccination to low-risk individuals are heavily debated and depend partly on the epidemiological impact and cost-effectiveness of such options. Marc Baguelin, Albert Jan Van Hoek and colleagues from the Health Protection Agency and the London School of Hygiene and Tropical Medicine in the UK describe how they fit a mathematical model to the estimated number of cases in real-time to predict the effectiveness of alternative influenza vaccination strategies. Specifically, they show that, vaccination of high risk groups was probably very cost effective. However, the cost-effectiveness of vaccinating kids depended on the progress of the epidemic and may be cost-effective in countries where a flu pandemic is not so far advanced.

“Given the present debates in different European countries about the legitimacy of the different choices of vaccination our paper is very topical,” stated Baguelin, “further it reinforces and expands a recent article in The Lancet (doi:10.1016/s0140-6736(09)62126-7) as it also suggests that many more people than first thought were infected in the summer wave of the swine flu pandemic.”

Story Source:

Adapted from materials provided by Elsevier, via EurekAlert!, a service of AAAS.

Journal Reference:

Baguelin et al. Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation. Vaccine, 2010; DOI: 10.1016/j.vaccine.2010.01.002

Note: If no author is given, the source is cited instead.

source : www.sciencedaily.com

Related News:

• Healthpoint Initiates Randomized, Double-Blind Study To Evaluate Effectiveness Of Collagenase SANTYL® Ointment On Healing Of Diabetic Foot Ulcers
• Study Says More Research Needed To Verify Effectiveness Of ACL And Knee Injury Prevention Programs
• New Published Tolerability Study Supports Effectiveness Of Formula In Helping To Prevent Recurring Urinary Tract Infections
• USPSTF To Update Osteoporosis Guidelines With Recos For Screening Men And Women At Low Risk For Fracture
• Ophthalmologist Nominated For Patient Centered Outcomes Institute Governing Board
• Top-Line Human Clinical Study Results Demonstrate Safety And Preliminary Effectiveness Of Cohera Medical’s TissuGlu(R)
• New Data Reinforces The Proven Safety And Effectiveness Of The BIRMINGHAM HIP Resurfacing System
• New Study Evaluates Effectiveness Of Vitamins For The Treatment Of Sun-Damaged Skin
• Cancer drug effectiveness substantially advanced: Co-administered peptide directs medicines deep into tumor tissue
• Increasing Understanding Of Drug Metabolism Provides Key Knowledge About Drug Toxicity And Effectiveness

Details :
Submited at Monday, February 22nd, 2010 at 7:00 am on Infectious Disease by jessica
Comment RSS 2.0 - leave a comment - trackback